Optiver Holding
ANAB icon

Optiver Holding’s AnaptysBio ANAB Stock Holding History

Optiver Holding’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04K Buy
+45
New +$2.73K ﹤0.01% 2166
2026
Q1 		– Sell
-54
Closed -$2.62K – 2316
2025
Q4 		$2.62K Sell
54
-36
-40% -$1.4K ﹤0.01% 1855
2025
Q3 		$2.76K Buy
+90
New +$2.06K ﹤0.01% 2236

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Optiver Holding's ANAB Position: Q2 2026 in Review

Optiver Holding opened a new position in AnaptysBio (ANAB) in Q2 2026: 45 shares worth $3.04K. The stake represents ﹤0.01% of the portfolio and ranks #2166 among its holdings. This is a return to the name: Optiver Holding previously reported a position in ANAB as recently as Q4 2025.

Optiver Holding first reported a position in ANAB in Q3 2025 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Optiver Holding held 45 shares of AnaptysBio worth $3.04K as of Q2 2026.
  • AnaptysBio was a new Optiver Holding position in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2166 holding.
  • Optiver Holding first reported a position in AnaptysBio in Q3 2025 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.